[1]李俊洋,张艮龙.2004-2023年肝细胞癌与细胞凋亡研究的文献计量及可视化分析[J].医学信息,2025,38(17):44-56.[doi:10.3969/j.issn.1006-1959.2025.17.006]
　LI Junyang,ZHANG Genlong.Bibliometrics and Visual Analysis of Hepatocellular Carcinoma and Apoptosis from 2004 to 2023[J].Journal of Medical Information,2025,38(17):44-56.[doi:10.3969/j.issn.1006-1959.2025.17.006]
点击复制

2004-2023年肝细胞癌与细胞凋亡研究的文献计量及可视化分析()

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年17期
页码:
44-56
栏目:
医学数据科学
出版日期:
2025-09-01

文章信息/Info

Title:
Bibliometrics and Visual Analysis of Hepatocellular Carcinoma and Apoptosis from 2004 to 2023
文章编号:
1006-1959（2025）17-0044-13
作者:
李俊洋; 张艮龙
安徽医科大学附属宿州市立医院普外五科，安徽 宿州 234000
Author(s):
LI Junyang;  ZHANG Genlong
Fifth Department of General Surgery, Suzhou Municipal Hospital Affiliated to Anhui Medical University, Suzhou 234000, Anhui, China
关键词:
肝细胞癌; 细胞凋亡; 文献计量; 可视化分析; CiteSpace; VOSviewer
Keywords:
Hepatocellular carcinoma;  Apoptosis;  Bibliometrics;  Visual analysis;  CiteSpace;  VOSviewer
分类号:
R735.7
DOI:
10.3969/j.issn.1006-1959.2025.17.006
文献标志码:
A
摘要:
目的 揭示肝细胞癌与细胞凋亡研究领域的研究热点分布情况，并进一步推测该领域未来的发展趋势。方法 使用Web of Science核心数据集（WOSCC）科学引文索引拓展版（SCIE）的主题检索式检索2004年1月1日-2023年12月31日有关肝细胞癌与细胞凋亡研究的相关文献，并在Excel 365、CiteSpace、VOSviewer和Charticulator中进行文献计量学及可视化分析。结果 共纳入5761篇文献，2004-2023年肝细胞癌与细胞凋亡的相关研究年发文量及年被引频次呈上升趋势，其中2018年以后发文量与被引频次激增。发文量最多的国家、机构和作者分别是中国、浙江大学和Li Y。共被引次数排在前3的作者分别是Llovet JM、Finn RS和Dixon SJ。发文最多的期刊是Frontiers in Oncology；被引频次最高的期刊是Hepatology；共被引频次最高的期刊Journal of Biological Chemistry。施引期刊主要来自Medicine（药物学）、Medical（医学）、Clinical（临床）、Molecular（分子）、Biology（生物学）和Immunology（免疫学）等领域，这些领域构成研究前沿；被引期刊主要来自于Molecular（分子）、Biology（生物学）、Genetics（遗传学）、Health（健康）、Nursing（护理学）和Medicine（药物学）等领域，这些领域构成研究基础。共被引频次排在首位的参考文献是“Sorafenib in Advanced Hepatocellular Carcinoma”。关键词聚类分析可分为5类，分别是肝细胞癌的治疗及其预后生存相关的研究领域、细胞凋亡及其相关的作用机制的研究领域、癌症细胞中基因的表达水平及其生物学行为的研究领域、细胞自噬及其实现机制的研究领域和细胞死亡、铁死亡及其相关机制的研究领域。免疫治疗、索拉非尼、肿瘤微环境、免疫检查点抑制剂和巨噬细胞等关键词未来会成为肝细胞癌与细胞凋亡研究相关的热点与前沿。结论 未来肝细胞癌与细胞凋亡研究领域的发文量和文献被引频次将继续增长。免疫治疗、索拉非尼、肿瘤微环境、免疫检查点抑制剂、巨噬细胞、铁死亡、细胞焦亡和铜死亡等未来会成为肝细胞癌与细胞凋亡研究相关的热点与前沿。
Abstract:
Objective To reveal the distribution of research hotspots in the field of hepatocellular carcinoma and apoptosis, and to further speculate the future development trend. Methods The related literatures on hepatocellular carcinoma and apoptosis from January 1, 2004 to December 31, 2023 were searched by using the subject retrieval method of Web of Science Core Collection (WOSCC) Science Citation Index Expanded Edition (SCIE), and bibliometrics and visual analysis were carried out in Excel 365, CiteSpace, VOSviewer and Charticulator. Results A total of 5761 documents were included in this study. From 2004 to 2023, the annual publication volume and annual citation frequency of research on hepatocellular carcinoma and apoptosis showed an upward trend, and the number of publications and citations increased sharply after 2018. The countries, institutions and authors with the largest number of publications were China, Zhejiang University and Li Y, respectively. The top three co-cited authors were Llovet JM, Finn RS and Dixon SJ. Frontiers in Oncology was the journal with the most publications; the most cited journal was Hepatology; the journal with the highest co-citation frequency was Journal of Biological Chemistry. The cited journals were mainly from the fields of Medicine, Medical, Clinical, Molecular, Biology and Immunology, which constitute the research frontier. Quoted journals were mainly from the fields of Molecular, Biology, Genetics, Health, Nursing and Medicine, which constitute the basis of research. The most frequently cited reference was “Sorafenib in Advanced Hepatocellular Carcinoma”. Keyword clustering analysis could be divided into five categories, namely, the research field related to the treatment and prognosis of hepatocellular carcinoma, the research field of apoptosis and its related mechanisms, the research field of gene expression level and biological behavior in cancer cells, the research field of autophagy and its realization mechanism, and the research field of cell death, ferroptosis and its related mechanisms. Keywords such as immunotherapy, sorafenib, tumor microenvironment, immune checkpoint inhibitors and macrophages would become hot spots and frontiers in the study of hepatocellular carcinoma and apoptosis in the future. Conclusion The number of publications and citations in the field of hepatocellular carcinoma and apoptosis will continue to increase in the future.Immunotherapy, sorafenib, tumor microenvironment, immune checkpoint inhibitors, macrophages, ferroptosis, pyroptosis, and copper death will become hot spots and frontiers in the study of hepatocellular carcinoma and apoptosis in the future.

参考文献/References:

[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Vogel A,Meyer T,Sapisochin G,et al Hepatocellular carcinoma[J].Lancet,2022,400(10360):1345-1362.[3]Tang D,Kang R,Berghe TV,et al.The molecular machinery of regulated cell death[J].Cell Res,2019,29(5):347-364.[4]Bertheloot D,Latz E,Franklin BS.Necroptosis, pyroptosis and apoptosis: an intricate game of cell death[J].Cell Mol Immunol,2021,18(5):1106-1121.[5]Newton K,Strasser A,Kayagaki N,et al.Cell death[J].Cell,2024,187(2):235-256.[6]Stockwell BR.Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications[J].Cell,2022,185(14):2401-2421.[7]Hicks D,Wouters P,Waltman L,et al.Bibliometrics: The Leiden Manifesto for research metrics[J].Nature,2015,520(7548):429-431.[8]Ninkov A,Frank JR,Maggio LA.Bibliometrics: Methods for studying academic publishing[J].Perspect Med Educ,2022,11(3):173-176.[9]Gong Y,Kang J,Wang M,et al.The trends and hotspots of immunotherapy for metastatic colorectal cancer from 2013 to 2022: A bibliometric and visual analysis[J].Hum Vaccin Immunother,2024,20(1):2312599.[10]Chen C.CiteSpace Ⅱ: Detecting and visualizing emerging trends and transient patterns in scientific literature [J].Journal of the American Society for information Science and Technology,2006,57(3):359-377.[11]van Eck NJ,Waltman L.Software survey: VOSviewer, a computer program for bibliometric mapping[J].Scientometrics,2010,84(2):523-538.[12]Ren D,Lee B,Brehmer M.Charticulator: Interactive Construction of Bespoke Chart Layouts[J].IEEE Trans Vis Comput Graph,2019(25):789-799.[13]Chen C,Leydesdorff L.Patterns of connections and movements in dual-map overlays: A new method of publication portfolio analysis[J].Journal of the Association for Information Science and Technology,2014,65(2):334-351.[14]He T,Zou J,Sun K,et al.Global research status and frontiers on autophagy in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis[J].Int J Surg,2024,110(5):2788-2802.[15]Li Z,Zhang Y,Zhang B,et al.Bibliometric study of immunotherapy for hepatocellular carcinoma[J].Front Immunol,2023,14:1210802.[16]Llovet JM,Ricci S,Mazzaferro V,et al.Sorafenib in advanced hepatocellular carcinoma[J].N Engl J Med,2008,359(4):378-390.[17]Qin S,Kudo M,Meyer T,et al.Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Phase 3 Randomized Clinical Trial[J].JAMA Oncol,2023,9(12):1651-1659.[18]Yau T,Park JW,Finn RS,et al.Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial[J].Lancet Oncol,2022,23(1):77-90.[19]Jemal A,Bray F,Center MM,et al.Global cancer statistics[J]..CA Cancer J Clin,2011,61(2):69-90.[20]Dixon SJ,Lemberg KM,Lamprecht MR,et al.Ferroptosis: an iron-dependent form of nonapoptotic cell death[J].Cell,2012,149(5):1060-1072.[21]Lei G,Zhuang L,Gan B.Targeting ferroptosis as a vulnerability in cancer[J].Nat Rev Cancer,2022,22(7):381-396.[22]Jiang Y,Yu Y,Pan Z,et al.Ferroptosis: a new hunter of hepatocellular carcinoma[J].Cell Death Discov,2024,10(1):136.[23]Singal AG,Llovet JM,Yarchoan M,et al.AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma[J].Hepatology,2023,78(6):1922-1965.[24]Hu M,Deng F,Song X,et al.The crosstalk between immune cells and tumor pyroptosis: advancing cancer immunotherapy strategies[J].J Exp Clin Cancer Res,2024,43(1):190.[25]Wu X,Cao J,Wan X,et al.Programmed cell death in hepatocellular carcinoma: mechanisms and therapeutic prospects[J].Cell Death Discov,2024,10(1):356.[26]Tsvetkov P,Coy S,Petrova B,et al.Copper induces cell death by targeting lipoylated TCA cycle proteins[J].Science,2022,375(6586):1254-1261.[27]Wu Z,Lv G,Xing F,et al.Copper in hepatocellular carcinoma: A double-edged sword with therapeutic potentials[J].Cancer Lett,2023,571:216348.[28]Zhang S,Huang Q,Ji T,et al.Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy[J].Biomark Res,2024,12(1):130.[29]Pikarsky E,Porat RM,Stein I,et al.NF-kappaB functions as a tumour promoter in inflammation-associated cancer[J].Nature,2004,431(7007):461-466.[30]Ferlay J,Soerjomataram I,Dikshit R et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):E359-E386.

相似文献/References:

[1]江亚楠,梁永新,施彩凤,等.右美托咪定在大鼠脊髓缺血再灌注损伤中的 保护作用及机制研究[J].医学信息,2018,31(07):69.[doi:10.3969/j.issn.1006-1959.2018.07.022]
　JIANG Ya-nan,LIANG Yong-xin,SHI Cai-feng,et al.Protective Effects and Mechanism of Dexmedetomidine on Spinal Cord Ischemia-Reperfusion Injury in Rats[J].Journal of Medical Information,2018,31(17):69.[doi:10.3969/j.issn.1006-1959.2018.07.022]
[2]王利娜,赵雪梅,徐云霞,等.磁共振扩散张量成像在肝细胞癌及 肝转移瘤鉴别诊断价值研究[J].医学信息,2018,31(09):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
　WANG Li-na,ZHAO Xue-mei,XU Yun-xia,et al.Diagnostic Value of Magnetic Resonance Diffusion Tensor Imaging in Hepatocellular Carcinoma and Liver Metastases[J].Journal of Medical Information,2018,31(17):12.[doi:10.3969/j.issn.1006-1959.2018.09.004]
[3]李 璟,蒋 娜,王晶晶,等.右美托咪定对H9C2心肌细胞缺氧/复氧损伤的保护作用[J].医学信息,2018,31(09):83.[doi:10.3969/j.issn.1006-1959.2018.09.025]
　LI Jing,JIANG Na,WANG Jing-jing,et al.Protective Effects of Dexmedetomidine on Hypoxia/Reoxygenation Injury in H9C2 Cardiomyocytes[J].Journal of Medical Information,2018,31(17):83.[doi:10.3969/j.issn.1006-1959.2018.09.025]
[4]季福水.AP-4、EZH2基因表达量与子宫内膜癌病灶中细胞凋亡、 上皮间质转化的相关性研究[J].医学信息,2018,31(14):92.[doi:10.3969/j.issn.1006-1959.2018.14.026]
　JI Fu-shui.Correlation between AP-4 and EZH2 Gene Expression Levels and Apoptosis and Epithelial-mesenchymal Transition in Endometrial Cancer[J].Journal of Medical Information,2018,31(17):92.[doi:10.3969/j.issn.1006-1959.2018.14.026]
[5]刘 冰,杨 帅,费锡斌,等.GPC-3联合CK-19免疫组化检测在肝细胞癌诊断及鉴别诊断中的应用[J].医学信息,2019,32(23):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
　LIU Bing,YANG Shuai,FEI Xi-bin,et al.Application of GPC-3 Combined with CK-19 Immunohistochemical Detection in Diagnosis and Differential Diagnosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(17):169.[doi:10.3969/j.issn.1006-1959.2019.23.054]
[6]李文华,许传斌,崔景景,等.基于治疗前MR-T2WI影像组学特征预测肝细胞癌射频消融术后早期复发的价值[J].医学信息,2022,35(18):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
　LI Wen-hua,XU Chuan-bin,CUI Jing-jing,et al.The Value of Predicting Early Recurrence of Hepatocellular Carcinoma After Radiofrequency Ablation Based on Pre-treatment MR-T2WI Radiomics Features[J].Journal of Medical Information,2022,35(17):39.[doi:10.3969/j.issn.1006-1959.2022.18.009]
[7]周文旭,谭湘淑,佘 君,等.类风湿关节炎大鼠滑膜细胞凋亡基因调控的实验研究[J].医学信息,2020,33(05):71.[doi:10.3969/j.issn.1006-1959.2020.05.021]
　ZHOU Wen-xu,TAN Xiang-shu,SHE Jun,et al.Experimental Study on Regulation of Apoptosis Genes in Synovial Cells of Rats with Rheumatoid Arthritis[J].Journal of Medical Information,2020,33(17):71.[doi:10.3969/j.issn.1006-1959.2020.05.021]
[8]张 莉,吴素琴,郭 毅,等.抗核抗体对人绒毛膜滋养层细胞系HTR8增殖及凋亡的影响[J].医学信息,2020,33(12):54.[doi:10.3969/j.issn.1006-1959.2020.12.017]
　ZHANG Li,WU Su-qin,GUO Yi,et al.Effects of Antinuclear Antibodies on the Proliferation and Apoptosis of Human Chorionic Trophoblast Cell Line HTR8[J].Journal of Medical Information,2020,33(17):54.[doi:10.3969/j.issn.1006-1959.2020.12.017]
[9]彭莉蓉,黎村艳,史 杨.肿瘤微环境免疫细胞中差异lncRNA对肝细胞癌预后的预测价值[J].医学信息,2022,35(20):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
　PENG Li-rong,LI Cun-yan,SHI Yang.The Predictive Value of Differential lncRNA in Tumor Microenvironment Immune Cells for the Prognosis of Hepatocellular Carcinoma[J].Journal of Medical Information,2022,35(17):18.[doi:10.3969/j.issn.1006-1959.2022.20.005]
[10]刘丽丽.CLCVP对肝细胞癌行腹腔镜肝叶切除手术相关指标及肝门阻断时间的影响[J].医学信息,2020,33(19):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]
　LIU Li-li.The Effect of CLCVP on the Operation-related Indexes and Port Occlusion Time in Patients with Hepatocellular Carcinoma Undergoing Laparoscopic Lobectomy[J].Journal of Medical Information,2020,33(17):88.[doi:10.3969/j.issn.1006-1959.2020.19.025]

更新日期/Last Update: 1900-01-01